VHL mutations were associated with the development of vascular tumors, such as renal clear cell carcinoma, pheochromocytoma, pancreatic neuroendocrine tumors, and central nervous system hemangioblastoma. Here, VHL is linked to pancreatic neuroendocrine tumor.